Assignee
KOLON TISSUEGENE INC
US·0 granted patents·17 pending applications·0 citations·filing 2019–2024
Top patents by PatentIndex Score
17 records- 0190US2025018011A1Treatment of intervertebral disc degenerationKOLON TISSUEGENE INC·Filed 2024·Application pending·0 cites
- 0290US2025090635A1Treatment of intervertebral disc degenerationKOLON TISSUEGENE INC·Filed 2024·Application pending·0 cites
- 0374US2021177939A1Treatment of intervertebral disc degenerationKOLON TISSUEGENE INC·Filed 2021·Application pending·0 cites
- 0474US2019224249A1Treatment of intervertebral disc degenerationKOLON TISSUEGENE INC·Filed 2019·Application pending·0 cites
- 0573US2021052662A1Treatment of intervertebral disc degenerationKOLON TISSUEGENE INC·Filed 2020·Application pending·0 cites
- 0668US2022241433A1Nerve regenerationKOLON TISSUEGENE INC·Filed 2021·Application pending·0 cites
- 0764US2022249573A1Cartilage regeneration using chondrocyte and tgf-betaKOLON TISSUEGENE INC·Filed 2021·Application pending·0 cites
- 0861US2022160780A1Mixed-cell gene therapyKOLON TISSUEGENE INC·Filed 2021·Application pending·0 cites
- 0961US2023256055A1Treatment of intervertebral disc degeneration and discogenic back painKOLON TISSUEGENE INC·Filed 2023·Application pending·0 cites
- 1061US2021052664A1Treatment of intervertebral disc degenerationKOLON TISSUEGENE INC·Filed 2020·Application pending·0 cites
- 1161US2023256025A1Treatment of intervertebral disc degeneration and discogenic back painKOLON TISSUEGENE INC·Filed 2023·Application pending·0 cites
- 1259US2022160834A1Treatment Of Intervertebral Disc DegenerationKOLON TISSUEGENE INC·Filed 2020·Application pending·0 cites
- 1354US2022160781A1Mixed-Cell Gene TherapyKOLON TISSUEGENE INC·Filed 2020·Application pending·0 cites
- 1452US2022193307A1Cartilage Regeneration Using Chondrocyte And TGF-BetaKOLON TISSUEGENE INC·Filed 2020·Application pending·0 cites
- 1552US2020270319A1Treatment of damaged nerve with pten inhibitorKOLON TISSUEGENE INC·Filed 2020·Application pending·0 cites
- 1648US2019224248A1Cartilage regeneration using chondrocyte and tgf-betaKOLON TISSUEGENE INC·Filed 2019·Application pending·0 cites
- 1745US2024115668A1Treatment of spinal cord injury with pten inhibitorKOLON TISSUEGENE INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when KOLON TISSUEGENE INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →